Biomembrane-Camouflaged Stents: Promising Strategies for Advanced Coronary Interventions
ACS Applied Materials & Interfaces · 04.11.2026 · 18 (43) · 58667-58692
DOI: 10.1021/acsami.6c11806 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 21.10.2026. Verfasst von Junyan Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. Hauptthemen laut MEDLINE: Stents, Biomimetic Materials, Coronary Artery Disease. Die Arbeit nennt 89 Literaturangaben.
Abstract (Originalsprache)
Coronary stent implantation remains a cornerstone therapy for coronary artery disease, yet current stent technologies continue to face limitations including acute and late thrombosis, delayed re-endothelialization, chronic inflammation, and in-stent restenosis. These complications largely arise from the nonphysiological interface between the implanted device and the injured vascular microenvironment. Biomembrane-camouflaged stents have recently emerged as a promising strategy to engineer biologically instructive blood-contacting surfaces by integrating natural or artificial membrane systems onto stent platforms. In this review, we summarize recent advances in three major biomembrane-based strategies for coronary stent functionalization: cell membrane-camouflaged stents, liposome-camouflaged stents, and exosome-camouflaged stents. Biomimetic cell membrane coatings retain native bioactive signals that collectively facilitate immune evasion, thromboresistance, and vascular healing. Liposome-based coatings are tunable artificial biomembrane reservoirs for the localized delivery of anticoagulants, anti-inflammatories, nitric oxide releasers, antiproliferatives, and gene therapies. Exosome-functionalized stents further enable bioactive intercellular communication by transferring endogenous regulatory cargos that modulate endothelial regeneration, macrophage polarization, smooth muscle cell phenotype, oxidative stress, and neointimal remodeling. We further discuss fabrication approaches, biological mechanisms, preclinical evidence, translational barriers, and future design principles for these platforms. Although challenges remain in coating durability, sterilization, long-term storage, manufacturing reproducibility, and clinical validation, biomembrane-camouflaged stents represent a compelling direction for next-generation coronary intervention by transforming conventional stents from passive mechanical scaffolds into active regulators of vascular repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
- Division of Nephrology, Institute of Kidney Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
- State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Department of Cariology and Endodontics, West China Hospital of Stomatology, Sichuan Univer…
ORCID-Profile: Jiaojiao Yang, Ping Fu, Yong He
Zitieren
APA
Zhang, J., Tao, S., Yang, J., Fu, P., Chen, Z., Rao, L., Tao, S., & He, Y. (2026). Biomembrane-Camouflaged Stents: Promising Strategies for Advanced Coronary Interventions. ACS Applied Materials & Interfaces, 18(43), 58667-58692. https://doi.org/10.1021/acsami.6c11806
Vancouver
Zhang J, Tao S, Yang J, Fu P, Chen Z, Rao L, et al. Biomembrane-Camouflaged Stents: Promising Strategies for Advanced Coronary Interventions. ACS Applied Materials & Interfaces. 2026;18(43):58667-58692. doi:10.1021/acsami.6c11806
BibTeX
@article{Zhang2026,
author = {Zhang, Junyan and Tao, Sibei and Yang, Jiaojiao and Fu, Ping and Chen, Zhongxiu and Rao, Li and Tao, Siying and He, Yong},
title = {Biomembrane-Camouflaged Stents: Promising Strategies for Advanced Coronary Interventions},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
volume = {18},
number = {43},
pages = {58667--58692},
doi = {10.1021/acsami.6c11806}
}
EUVIMED